Johnson & Johnson (JNJ) Q3 2021 Results - Earnings Call Transcript

Oct. 19, 2021 12:41 PM ETJohnson & Johnson (JNJ)
SA Transcripts profile picture
SA Transcripts

Johnson & Johnson (NYSE:JNJ) Q3 2021 Earnings Conference Call October 19, 2021 8:30 AM ET

Company Participants

Ashley McEvoy – Executive Vice President

Thibaut Mongon – Executive Vice President

Joseph Wolk – Executive Vice President

Jennifer Mc Intyre – Executive Vice President

Sarah Wood – Senior Director

Jen McIntyre – Investor Relations

Conference Call Participants

Chris Schott – JP Morgan

Josh Jennings – Cowen and Company

Larry Biegelsen – Wells Fargo

Matthew Harrison – Morgan Stanley

Matt Miksic with – Suisse

Danielle Antalffy – SVB Leerink


Good morning. Welcome to Johnson & Johnson's Third Quarter 2021 earnings conference call. All participants will be in listen-only mode until the question-and-answer session of the conference. This call is being recorded. If you have any objections, you may disconnect at this time. If you experience technical difficulties during the conference, [Operator Instructions]. I would now like to turn the call over to Johnson & Johnson. You may now begin.

Sarah Wood

Good morning. This is Sarah Wood, Senior Director, Investor Relations, for Johnson & Johnson. Welcome to our Company's review of business results for the third quarter and our updated financial outlook for 2021. On today's call is Joe Wolk, Executive Vice President, Chief Financial Officer; and So, during the Q and A portion of the call, Joe will be joined by Ashley McEvoy, Executive Vice President, and Worldwide Chair, Medical Devices. Thibaut Mongon, Executive Vice President and Worldwide Chair, Consumer Health, and Jennifer Taubert, Executive Vice President and Worldwide Chair Pharmaceuticals.

A few logistics before we get into the details. This review is being made available via webcast, accessible through the Investor Relations section of the Johnson & Johnson website at investor., where you can also find additional materials, including today's presentation and associated schedules. Please note that today's presentation includes forward-looking statements. We encourage you to review the

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.